SCLC-A and SCLC-N are characterized by increased NE phenotypes, high levels of NE markers (synaptophysin, chromogranin A, etc.), and high DLL3 expression compared to SCLC-P subtypes50. The gene discussed is SYP; the disease is small cell lung carcinoma.